News

IU Simon Comprehensive Cancer Center joins Caris' network of cancer institutions committed to utilizing clinical data to advance patient care and outcomes.

Study will test a range of therapies specifically targeting key genetic changes in cancer cells.

Results reveal shift in clinical trial priorities; payment efficiencies emerge as leading concern for sponsors, CROs, and sites.

Analysis of 117,000 patients reveals rapid rate of decline in Alzheimer’s patients with 18% loss in cognitive function over a 12-month period.

New updates address common industry challenges for RPM patient adherence in clinical trials and healthcare.

Automated platform enables monitoring of investigational product temperature from manufacturing through distribution to clinical research sites.

SIP SaaS solution has surpassed 250,000 users across 100 countries worldwide.

New custom-built, green-designed headquarters is now open in Overland Park, Kansas.

The latest business and people happenings from the last month, all in one place.

Industry leaders share insights on drug development challenges and trends in new survey.

New free-picking capabilities included in latest IRT release will be used for patient randomization and supply chain management.

DCT platform to deliver stronger evidence of therapeutic efficacy and safety.

Real-time monitoring module now available in SaaS-based platform.

Expanded services will provide faster timelines in the clinical trial process for early stage and clinical pharmacology research.

Medable selected by GSK to accelerate the delivery of new medicines and enable their clinical trials to be more inclusive and representative of all patient populations.

Study found faster, less expensive, and more engaging trials can be achieved using tech-enabled decentralized clinical trial models.

New program provides sites with customized support and monitoring of metrics related to adherence, compliance, data management, and technology use.

Report outlines performance of ICON's ESG commitments in areas such as public health and ethics.

Study will focus on immune response to COVID-19 vaccinations of people living with multiple sclerosis.

Report seeks to understand how 300 participants perceived terminology which is commonly found across healthcare and medical literature.

Partnership will enable convenient patient medical testing services for DCTs.

Investment will increase the site’s size to 31,000 square feet and allow the installation of 35 new freezers for ULT storage.

North Carolina base will provide access to the organization's clinical trial agreement and negotiation services.

MCWCC joins Caris' network of leading cancer institutions committed to utilizing clinical data to advance patient care and outcomes.

New solution will address needs in oncology clinical research, with a special focus on emerging biotechs.

Solutions include pre-configured modules for vaccine clinical trials that increase operational efficiency.

New partnership will advance multiple myeloma drug discovery and clinical development.

New partnership will accelerate Phase III study in patients with atrial fibrillation.

CRO expands its Early Phase large molecule capabilities and services with a new 15,000 square foot dedicated lab.

Study focuses on three major therapy areas; neurology, oncology, and cardiology, which digital biomarkers impact.